Researchers at Royal Cornwall Hospitals NHS Trust are running a new study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
The NIHR-supported Novavax COVID-19 vaccine – which was trialled in Exeter and Cornwall – has demonstrated that the vaccine is 89.3% effective at preventing COVID-19. This data was identified from interim analysis of the Phase III study and included effectiveness against the new variants.
A home-based rehabilitation programme that could help thousands of heart failure patients to achieve a better quality of life has won a prestigious BMJ award.
